Tracker trials

BMJ

Volumn 320, Issue 7251, 2000, Pages 1727-

  Dunn, David ^a   Mccormack, Sheena ^a   Babiker, Abdel ^a   Darbyshire, Janet ^a   Thornton, Hazel ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b Colchester ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007684401     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.320.7251.1727/a     Document Type: Letter

References (6)

1. Lilford RJ, Braunholtz DA, Greenhalgh R, Edwards SJL. Trials and fast changing technologies: the case for tracker studies. BMJ 2000; 230: 43–46. (1 January.)
2. Rodriguez-Rosado R, Briones C, Soriano V. Introduction of HIV drug resistance testing in clinical practice. AIDS 1999; 13: 1007–1014.
3. Loveday C, Dunn D, McCormack S, Babiker A. The use of HIV resistance assays—random or randomised? Sex Transm Infect 1999; 75: 140–141.
4. Schuurman R, Brambilla D, de Groot T, Boucher C. Second worldwide evaluation of HIV-1 drug resistance genotyping quality using the ENVA 2 panel. Antiviral Ther 1999; 4(supplement 1): 41.
5. Support for non-competitive trials [editorial]. Lancet 1999; 353: 855.
6. Lilford RJ, Braunholtz DA, Greenhalgh R, Edwards SJL. Trials and fast changing technologies: the case for tracker studies. BMJ 2000; 230: 43–46. (1 January.)